🟢 Clover Health is trading 4.18% up in pre-market; no confirmed company-specific reason

Clover Health is trading 4.18% higher in pre-market at $4.49 on November 3, 2026, with no confirmed company-specific announcement explaining the move.

• Shares closed at $4.31 on November 2.
• Clover Health is scheduled to report Q3 2026 results after the market closes on November 4. A published preview expects revenue of $740.31 million and EPS of -$0.01; the upcoming report does not establish the reason for the gain.